Koyfin Home > Directory > Health Care > Aeglea Biothera > Cash Flow from Operations

Aeglea Biothera Cash Flow from Operations Chart (AGLE)

Aeglea Biothera annual/quarterly Cash Flow from Operations from 2014 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Aeglea Biothera Cash Flow from Operations for the quarter ending June 06, 2020 was $-19m a 11.36% decrease of -2m year over year
  • Aeglea Biothera Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-75m a 24.14% decrease of -18m year over year
  • Aeglea Biothera Annual Cash Flow from Operations for 2019 was $-66m a 50.99% decrease of -33m from 2018
  • Aeglea Biothera Annual Cash Flow from Operations for 2018 was $-32m a 23.54% decrease of -8m from 2017
  • Aeglea Biothera Annual Cash Flow from Operations for 2017 was $-25m a 23.46% decrease of -6m from 2016
Other Cash Flow Metrics:
  • Aeglea Biothera Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-6m a 25.45% decrease of -2m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE Cash Flow from Operations Data

06/2020$-19m
03/2020$-22m
12/2019$-16m
09/2019$-17m
06/2019$-16m
03/2019$-16m
12/2018$-7m
09/2018$-9m
06/2018$-9m
03/2018$-7m

Annual AGLE Cash Flow from Operations Data

2019$-66m
2018$-32m
2017$-25m
2016$-19m
2015$-11m
2014$-7m
2013$-4m